CD36-TSP-HRGP Interactions in the Regulation of Angiogenesis
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3559-3567
Author(s):
Roy L. Silverstein and Maria Febbraio
Identification of Novel Drug Targets for Angiostatic Cancer Therapy; It Takes Two to Tango
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3576-3583
Author(s):
Victor L.J.L. Thijssen, Judy R. van Beijnum, Kevin H. Mayo and Arjan W. Griffioen
Modulation of Angiogenesis for Cancer Prevention: Strategies Based On Antioxidants and Copper Deficiency
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3584-3590
Author(s):
Gazala N. Khan and Sofia D. Merajver
Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3622-3636
Author(s):
Kosmas I. Paraskevas, Alexandros A. Tzovaras, Despina D. Briana and Dimitri P. Mikhailidis
Ultrasound-Directed Drug Delivery
Journal:
Current Pharmaceutical Biotechnology
Volume:
8
Page:
355-361
Author(s):
Michiel Postema and Odd Helge Gilja
Epigenetic Lesions in Malignant Melanoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
8
Page:
382-387
Author(s):
M. Schwabe and M. Lubbert
Innovative Drug Delivery Systems for the Administration of Natural Compounds
Journal:
Current Bioactive Compounds
Volume:
3
Page:
262-277
Author(s):
Donatella Paolino, Donato Cosco, Felisa Cilurzo and Massimo Fresta
How Do Microtubule-Targeted Drugs Work? An Overview
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
730-742
Author(s):
Mary Ann Jordan and Kathy Kamath
Molecular and Cellular Regulators of Cancer Angiogenesis
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
743-758
Author(s):
P. P. Goh, D. M. Sze and B. D. Roufogalis
Radiosensitization of Prostate Cancer by Soy Isoflavones
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
759-765
Author(s):
Julian J. Raffoul, Fazlul H. Sarkar and Gilda G. Hillman